NCT02047474 - Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 25, 2014

Primary Completion Date

February 28, 2026

Study Completion Date

December 31, 2026

Conditions

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage I Pancreatic CancerStage IIA Pancreatic CancerStage IIB Pancreatic Cancer

Interventions

DRUG

oxaliplatin

Given IV

DRUG

leucovorin calcium

Given IV

DRUG

irinotecan hydrochloride

Given IV

DRUG

fluorouracil

Given IV

PROCEDURE

therapeutic conventional surgery

Undergo surgical resection

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (9)

06824

Smilow Cancer Hospital at Fairfield, Fairfield

06437

Smilow Cancer Hospital at Guilford, Guilford

06105

Smilow Cancer Hospital at St. Francis Hospital, Hartford

06520-8032

Yale University, New Haven

06473

Smilow Cancer Hospital at North Haven, North Haven

06477

Smilow Cancer Hospital at Orange, Orange

06790

Smilow Cancer Hospital at Torrington, Torrington

06611

Smilow Cancer Hospital at Trumbull, Trumbull

06708

Smilow Cancer Hospital at Waterbury, Waterbury

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER